Long-Term Safety, Tolerability, and Efficacy of DTX101 (AAVrh10FIX) in Adults With Moderate/Severe to Severe Hemophilia B
Clinical trial NCT02971969 · COMPLETED
Trial details
- NCT number
- NCT02971969
- Sponsor
- Ultragenyx Pharmaceutical Inc
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-01-01
- Primary completion
- 2021-11-06
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.